Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...

Before markets open, start your day smart. Get essential news and analysis with CNN Business' daily newsletter.

2 Auxiliary Fuel Tanks (ACTs) for over 4000 nm of range non-stop (Middle East to Europe - Europe to US East Coast – Asia to Middle East) ...